VVUS

VIVUS, Inc. News Headlines

$1.51
*  
0.22
12.72%
Get VVUS Alerts
*Delayed - data as of Jul. 31, 2015  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By









Vivus Reports Q2 Loss- Confirms Obesity Sector Weakness
7/31/2015 8:21:00 AM - Seeking Alpha




Orexigen: Contrave Sales Up 2.75% - Still No News On Europe
7/27/2015 11:48:00 AM - Seeking Alpha


Arena: Sales Flat Again- Belviq Still Losing Market Share
7/27/2015 10:15:00 AM - Seeking Alpha




Vivus- Qsymia Sales Trending Down Again
7/20/2015 12:52:00 PM - Seeking Alpha




Orexigen- Contrave Sales Dip Despite Market Leadership
7/13/2015 7:27:00 AM - Seeking Alpha






Arena - Belviq Sales Slide Again
7/7/2015 2:51:00 AM - Seeking Alpha


Vivus - Qsymia Sales Dip And Flatten Out
7/6/2015 4:25:00 PM - Seeking Alpha










The Anti-Obesity Sector In Q2 Is Not Looking Good
6/23/2015 1:03:00 PM - Seeking Alpha


Vivus: Something You Would Want To Know About Qsymia
6/23/2015 12:45:00 PM - Seeking Alpha


Vivus- Qsymia Sales Dip From Peak In Previous Week
6/22/2015 2:37:00 PM - Seeking Alpha